Key Record Dates
ClinicalTrials.gov Identifier: | NCT01675154 |
---|---|
Brief Title: | Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia |
First Submitted : | August 27, 2012 |
First Submitted that Met QC Criteria : | August 28, 2012 |
First Posted : | August 29, 2012 (Estimate) |
Results First Submitted : | May 21, 2021 |
Results First Submitted that Met QC Criteria : | July 26, 2021 |
Results First Posted : | August 19, 2021 |
Last Update Submitted that Met QC Criteria : | July 26, 2021 |
Last Update Posted : | August 19, 2021 |